Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marcia R. Silver"'
Publikováno v:
Journal of the American Medical Directors Association. 8:83-90
Objectives: To evaluate the efficacy of once-monthly darbepoetin alfa in maintaining hemoglobin (Hb) levels between 10 and 12 g/dL in older subjects receiving darbepoetin alfa every 2 weeks. Design:Asecondaryanalysisofa29-weekmulticenter, open-label,
Autor:
Marcia R. Silver, Michelle W. Krause, Reshma Kewalramani, C. Y. Chen, R. Geronemus, Catherine Stehman-Breen
Publikováno v:
Current medical research and opinion. 25(1)
To evaluate the efficacy and safety of darbepoetin alfa dosed every-other-week (Q2W) to treat anemia in subjects with chronic kidney disease (CKD), not receiving dialysis, who were naïve to erythropoiesis-stimulating agent (ESA) therapy.This was an
Publikováno v:
The American journal of geriatric pharmacotherapy. 6(2)
Background: The anemia of chronic kidney disease (CKD) is associated with increased hospitalizations, increased cardiovascular morbidity and mortality, and diminished quality of life in the elderly. Darbepoetin alfa is an erythropoiesis-stimulating a